The London High Court on Tuesday dismissed a N$1.3 billion claim against Namibian-based British businessman Harvey Boulter, brought by liquidated company Enigma Diagnostics.
A pharmaceutical company was last Wednesday granted an interdict to stop the implementation of a N$1.3 billion tender, awarded to a company whose majority shareholder is a.
The Central Procurement Board of Namibia’s (CPBN) review panel is sticking to its guns and has cemented its decision to award a billion-dollar medical supply tender to Cospharm.
The Central Procurement Board of Namibia has been prohibited from implementing or executing any procurement contract awarded to Cospharm Investments.This after Africure.
The Central Procurement Board of Namibia’s (CPBN) decision to award a N$1.3 billion contract to a company majority-owned by a five-year-old girl is intensifying scrutiny of a.